v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | RBR-6m69fc |
Full text link
Last imported at : Jan. 8, 2021, 12:45 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
|
First author
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
|
Contact
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
cbernal495@gmail.com |
Registration date
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
2020-04-02 |
Recruitment status
Last imported at : Dec. 10, 2021, 2 p.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Not recruiting |
Study design
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Randomized |
Design
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Blind label |
Center
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
unclear |
Study aim
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Treatment |
Inclusion criteria
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Patients between 18-75 years who are affected by coronavirus (COVID-19), and are in home confinement. |
Exclusion criteria
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Patients with chronic lung conditions, Patients with chronic kidney disease, Patients affected with chronic neurological disorders, Patients suffering from hypertension and cardiovascular conditions without medical treatment, Patients affected with grade III osteoporosis, Patients affected with acute outbreaks of rheumatologic disorders, Patients affected with acute outbreaks disc abnormalities, Patients who have had respiratory conditions in the last 12 months, Patients who have recent musculoskeletal disorders, and who are not fully recovered from their injuries, Patients who have received physical therapy treatment in the last 3 months, Patients affected with chronic mental and / or psychological disturbances, Red Flags (Night pain, severe muscle spasm, loss of involuntary weight, symptom mismatch) |
Number of arms
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
3 |
Funding
Last imported at : Dec. 15, 2020, 2:47 p.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Universidad de Sevilla |
Inclusion age min
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
18 |
Inclusion age max
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
75 |
Countries
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Spain |
Type of patients
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Mild/moderate disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
2: Mild/moderate disease at enrollment |
Total sample size
Last imported at : Dec. 15, 2020, 2:47 p.m. Source : International Clinical Trials Registry Platform (ICTRP) |
0 |
primary outcome
Last imported at : Dec. 10, 2021, 2 p.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Multidimensional Dysphnoea-12 (MD12) Spanish version. The MD12 questionnaire will be self-administered and will be performed at the end of the 6MWT. Patients will send the results of MD12 screenshot daily to the evaluator; via WhatsApp or email. ;Six Minute Walk Test (6MWT). The 6MWT will be performed by all patients in their home; under the telematically supervision of a physiotherapist. All patients will receive the same instructions before the walk; and will be encouraged by the physiotherapist who repeated set phrases every minute during the walk. The distance covered during the test will be recorded in meters telematically by patient smartphone. Patients will be allowed to stop and rest during the test but they will be instructed to resume walking as soon as they felt able to do so. Patients will send the results of 6MWT screenshot daily to the evaluator; via WhatsApp or email. ;hirty Seconds Sit-To-Stand Test (30STST). Evaluators will ask patients to place a straight-backed armless chair; with a hard seat ; which will be stabilized by placing it against a wall; considering floor to seat height will be between 45 - 50 cm. Seated participants will asked to come forward on the seat until their feet will be flat on the floor; and to fold their upper limbs across the chest; without moving it during all test. Patients will be then instructed to stand up all the way and sit down once without using the upper limbs. Patients will start in the seated position on the chair and; upon command telematically; they will stand up; and then they will return to sitting as many times as they could; in a 30-second time period. The evaluators will control this test telematically by videoconference. |
Notes
Last imported at : Dec. 10, 2021, 2 p.m. Source : International Clinical Trials Registry Platform (ICTRP) |
|
Phase
Last imported at : Oct. 26, 2020, 8:29 a.m. Source : International Clinical Trials Registry Platform (ICTRP) |
Not reported |
Arms
Last imported at : Dec. 10, 2021, 2 p.m. Source : International Clinical Trials Registry Platform (ICTRP) |
[{"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": 1108, "treatment_name": "Respiratory exercise program (rep)", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 907, "treatment_name": "Non-specific toning exercise program (ntep)", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}] |